Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECIGEN, INC. Director's Dealing 2025

Mar 17, 2025

32044_dirs_2025-03-17_392ac188-f21c-4bba-bf09-a08374909435.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2025-03-13

Reporting Person: Gupta Vinita D (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-13 Common Stock A 36206 $1.74 Acquired 488828 Direct
2025-03-14 Common Stock M 87412 Acquired 576240 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-03-13 Restricted Stock Units $ A 71839 Acquired Common Stock (71839) Direct
2025-03-14 Restricted Stock Units $ M 87412 Disposed Common Stock (87412) Direct
2025-03-13 Option to Purchase Common Stock (Right to Buy) $1.74 A 83517 Acquired 2035-03-13 Common Stock (83517) Direct

Footnotes

F1: The shares were issued to the reporting person in lieu of an annual retainer of $63,000.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.

F3: The RSUs vest in full on March 13, 2026.

F4: The RSUs vested in full on March 14, 2025.